Grazax

DRUG8 trials

Conditions

Allergic RhinitisAllergic Rhinitis Due to Grass PollensAllergic RhinoconjunctivitisAllergyGrass Pollen Allergy

Phase 2

Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study

CompletedNCT02005627

Imperial College LondonAllergic Rhinitis

Start: 2013-09-01End: 2017-03-01Updated: 2019-12-04

Phase 3

A Trial of Grazax in Subjects With Hayfever

CompletedNCT00421655

ALK-Abelló A/SAllergy

Start: 2006-12-31End: 2007-10-31Updated: 2015-06-24

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

CompletedNCT00773240

ALK-Abelló A/SGrass Pollen Allergy

Start: 2008-04-30End: 2009-02-28Updated: 2011-08-30

Grazax Asthma Prevention

CompletedNCT01061203

ALK-Abelló A/SAllergic Rhinitis

Start: 2010-01-31End: 2015-09-30Updated: 2016-09-08

Phase 4

Tolerability of Grazax in Patients With Hayfever in Real Life Settings

CompletedNCT01433510

ALK-Abelló A/SAllergic Rhinoconjunctivitis

Start: 2007-11-30End: 2010-12-31Updated: 2024-05-29

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

CompletedNCT01854736

ALK-Abelló A/SAllergic Rhinitis Due to Grass Pollens

Start: 2013-04-30End: 2015-12-31Updated: 2017-06-28

Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®

CompletedNCT02437786

ALK-Abelló A/SAllergic Rhinoconjunctivitis

Start: 2009-09-30End: 2014-12-31Updated: 2018-01-17

Unknown Phase

Standardising Nasal Allergen Challenge in Adult With Hay Fever

CompletedNCT04078009

Imperial College LondonAllergic Rhinitis

Start: 2019-09-26End: 2020-08-28Updated: 2021-08-31

Related Papers

Protocol for a randomised, double‐blind, placebo‐controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes

Clinical and Translational Allergy2015-01-014 citations

A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma

Journal of Negative Results in BioMedicine2013-06-0146 citations

Safety and tolerability of an SQ-standardized GRAss ALlergy immunotherapy tablet (GRAZAX®) in a real-life setting for three consecutive seasons - the GRAAL trial.

2012-07-0114 citations